{
    "code": "01022587",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01022587",
    "time": "2022-03-18 03:01:33",
    "許可證字號": "衛署藥製字第022587號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/12\/08",
    "發證\/登錄日期": "69\/12\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00102258704",
    "中文品名": "清淨癌注射液",
    "英文品名": "&quot;Y.H.&quot; FLUOROURACIL INJECTION",
    "適應症": "結腸癌、直腸癌、乳癌、胃癌、胰臟癌、不可以手術之胃腸道乳部惡性腫瘤的姑息療法",
    "劑型": "270注射劑",
    "包裝": "盒裝 安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "FLUOROURACIL 5-, SODIUM HYDROXIDE, WATER FOR INJECTION",
    "限制項目": "01國　產 1R不得製造",
    "申請商名稱": "6201021021  育新企業股份有限公司",
    "申請商地址": "新北市汐止區大同路一段239號16樓之1",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008400201",
            "成分名稱": "FLUOROURACIL 5-",
            "含量描述": "250",
            "含量": "250.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9600028200",
            "成分名稱": "SODIUM HYDROXIDE",
            "含量描述": "(SOLUTION 40%)",
            "含量": "",
            "單位": "Q.S."
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9604000900",
            "成分名稱": "WATER FOR INJECTION",
            "含量描述": "(ADD TO) 5",
            "含量": "",
            "單位": "ML"
        }
    ]
}